Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;34(4):490-500.
doi: 10.1111/j.1540-8159.2010.03014.x.

Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach

Amy L Miller  1 , Daniel B Kramer, Eldrin F Lewis, Bruce Koplan, Laurence M Epstein, Usha Tedrow
Affiliations

Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach

Amy L Miller et al. Pacing Clin Electrophysiol. 2011 Apr.

Abstract

Background: While surgical epicardial lead placement is performed in a subset of cardiac resynchronization therapy patients, data comparing survival following surgical versus transvenous lead placement are limited. We hypothesized that surgical procedures would be associated with increased mortality risk.

Methods: Long-term event-free survival was assessed for 480 consecutive patients undergoing surgical (48) or percutaneous (432) left ventricle (LV) lead placement at our institution from January 2000 to September 2008.

Results: Baseline clinical and demographic characteristics were similar between groups. While there was no statistically significant difference in overall event-free survival (P = 0.13), when analysis was restricted to surgical patients with isolated surgical lead placement (n = 28), event-free survival was significantly lower in surgical patients (P = 0.015). There appeared to be an early risk (first approximately 3 months postimplantation) with surgical lead placement, primarily in LV lead-only patients. Event rates were significantly higher in LV lead-only surgical patients than in transvenous patients in the first 3 months (P = 0.006). In proportional hazards analysis comparing isolated surgical LV lead placement to transvenous lead placement, adjusted hazard ratios were 1.8 ([1.1,2.7] P = 0.02) and 1.3 ([1.0,1.7] P = 0.07) for the first 3 months and for the full duration of follow-up, respectively.

Conclusions: Isolated surgical LV lead placement appears to carry a small but significant upfront mortality cost, with risk extending beyond the immediate postoperative period. Long-term survival is similar, suggesting those surviving beyond this period of early risk derive the same benefit as coronary sinus lead recipients. Further work is needed to identify risk factors associated with early mortality following surgical lead placement.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Survival (free from all-cause mortality) as a function to time post-CRT initiation for patients with TV-CS leads (solid line) and surgical LV leads (dotted line). Number of patients in each group, by year, shown below x-axis. (B) Time post-CRT initiation free from the composite end-point (Transplant, VAD, death), for patients with TV-CS leads (solid line) and surgical LV leads (dotted line). Number of patients in each group, by year, shown below x-axis.
Figure 1
Figure 1
(A) Survival (free from all-cause mortality) as a function to time post-CRT initiation for patients with TV-CS leads (solid line) and surgical LV leads (dotted line). Number of patients in each group, by year, shown below x-axis. (B) Time post-CRT initiation free from the composite end-point (Transplant, VAD, death), for patients with TV-CS leads (solid line) and surgical LV leads (dotted line). Number of patients in each group, by year, shown below x-axis.
Figure 2
Figure 2. Event-free survival for individual surgical groups
Time post-CRT initiation free from the composite end-point (Transplant, VAD, death), for patients who underwent LV-only surgery (black solid line) and LV lead placement at the time of bypass or valve (black dotted line). Patients with a TV-CS lead are shown in solid gray (matches Figure 1B solid line). Patients for whom TV-CS lead attempt failed, and who were not subsequently referred for surgical lead placement (i.e., no CRT performed) are also shown as a function of time after attempted CRT (gray dashed line). Number of patients at risk in each group, by year, is shown below x-axis.
See this image and copyright information in PMC

References

    1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, III, Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1–62. - PubMed
    1. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Journal of the American College of Cardiology. 2002;39:2026–2033. - PubMed
    1. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. Journal of the American College of Cardiology. 2003;42:1454–1459. - PubMed
    1. Higgins SL, Yong P, Scheck D, McDaniel M, Bollinger F, Vadecha M, Desai S, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Journal of the American College of Cardiology. 2000;36:824–827. - PubMed
    1. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, Hartling L, et al. Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure. Annals of Internal Medicine. 2004;141 381-W-375. - PubMed

Publication types